◀ Back to FOS
CDK4 — FOS
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Ino et al., J Neurosci 2001
:
Although KA administration causes prolonged c-Fos expression in the vulnerable regions that preceded the induction of neuronal apoptosis, the
CDK4 or cyclin D1 antisense oligonucleotides exhibited no suppressive
effect on
c-Fos levels
Shen et al., Cell Biol Int 2008
(MAP Kinase Signaling System...) :
Activator protein-1 (AP-1) was
responsible for the decrease of
CDK4 expression level, but not that of cyclin D1
Vanden Bush et al., PloS one 2011
:
Additionally, the activity of
AP-1 , a ubiquitous transcription factor containing phosphorylated c-Jun as a subunit, was
inhibited by abrogating
CDK4
Jalili et al., J Natl Cancer Inst 2012
(MAP Kinase Signaling System...) :
Using a dominant negative approach, in vitro cell proliferation assays, western blots, and flow cytometry showed that MAPK signaling via BRAF ( V600E ) promotes melanoma cell proliferation at G1 through
AP-1 mediated negative regulation of the INK4 family member,
cyclin dependent kinase inhibitor 2C ( CDKN2C ), and the CIP/KIP family member, cyclin dependent kinase inhibitor 1A ( CDKN1A )